Loading...

ABCL ABCELLERA BIOLOGICS INC Earnings Reports 8-K Filing

BCLL

BCL

ABCELLERA BIOLOGICS INC

(ABCL)

2025 8-K

Show Summary

Summary

Financial Statements

Clinical Trials

Clinical Trials

Regulatory Compliance

Financial Statements

Earnings Results

Management Change

Earnings Announcement

Earnings Reports

Annual Meeting of Shareholders

Departure of Directors

Financial Results Announcement

Workforce Reduction

Ownership of Antibody Drug ...

Annual Meeting of Shareholders

Investment Agreement

Regulation FD Disclosure

External Links:

On February 27, 2025, AbCellera Biologics Inc. announced its financial and operational results for the year ended December 31, 2024, along with a corporate presentation for its earnings call.

AI Assistant

ABCELLERA BIOLOGICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.